Ozempic and other weight-loss drugs will power the anti-obesity market to 16-fold gains by 2030, Goldman Sachs says

Tech Insider
Ozempic box
Weight-loss drugs could fuel huge gains for the anti-obesity market, according to Goldman Sachs.

Getty Images

Subscribe to eli-lilly